Johnson & Johnson (JNJ) Shareholder Reilly Financial Advisors LLC Has Increased Its Holding

June 20, 2017 - By Stephen Andrade

Investors sentiment increased to 0.94 in Q4 2016. Its up 0.12, from 0.82 in 2016Q3. It is positive, as 63 investors sold JNJ shares while 834 reduced holdings. 114 funds opened positions while 731 raised stakes. 1.72 billion shares or 0.88% more from 1.71 billion shares in 2016Q3 were reported. Advisory Rech accumulated 8,630 shares or 0.01% of the stock. Accredited reported 0.13% stake. Schmidt P J Inv Mngmt Incorporated accumulated 65,793 shares. Kings Point invested 0.37% in Johnson & Johnson (NYSE:JNJ). Efg Asset Management (Americas) Corp owns 8,093 shares for 0.42% of their portfolio. Johnson Gp stated it has 0.92% in Johnson & Johnson (NYSE:JNJ). Palisade Capital Management Lc Nj reported 89,391 shares. Manitoba – Canada-based Tetrem Mngmt has invested 2.63% in Johnson & Johnson (NYSE:JNJ). Patten Gru Inc stated it has 1.35% in Johnson & Johnson (NYSE:JNJ). New York-based Williams Jones Limited Liability Co has invested 1.93% in Johnson & Johnson (NYSE:JNJ). Beacon owns 39,061 shares. Shamrock Asset Mngmt Ltd invested 0.6% in Johnson & Johnson (NYSE:JNJ). Solaris Asset Mngmt Llc has 1,609 shares for 0.12% of their portfolio. Arcadia Invest Corp Mi, Michigan-based fund reported 6,763 shares. 113,462 were accumulated by Violich Cap Mngmt.

Since February 1, 2017, it had 0 buys, and 5 insider sales for $14.98 million activity. On Wednesday, February 15 Stoffels Paulus sold $2.58 million worth of Johnson & Johnson (NYSE:JNJ) or 22,000 shares. Pruden Gary J sold 16,299 shares worth $1.99M. Duato Joaquin also sold $6.18 million worth of Johnson & Johnson (NYSE:JNJ) on Friday, March 3. Another trade for 14,543 shares valued at $1.78M was made by Kapusta Ronald A on Tuesday, February 28. Ullmann Michael H had sold 21,735 shares worth $2.45 million on Wednesday, February 1.

Reilly Financial Advisors Llc increased its stake in Johnson & Johnson (JNJ) by 360.96% based on its latest 2016Q4 regulatory filing with the SEC. Reilly Financial Advisors Llc bought 70,939 shares as the company’s stock rose 6.85% with the market. The institutional investor held 90,592 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $10.44M, up from 19,653 at the end of the previous reported quarter. Reilly Financial Advisors Llc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $364.72B market cap company. The stock decreased 0.21% or $0.28 during the last trading session, reaching $134.07. About shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since June 20, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Reilly Financial Advisors Llc, which manages about $679.11M and $578.45M US Long portfolio, decreased its stake in Graphic Packaging Hldg Co (NYSE:GPK) by 536,657 shares to 7,280 shares, valued at $91,000 in 2016Q4, according to the filing. It also reduced its holding in Cvs Health Corp (NYSE:CVS) by 109,725 shares in the quarter, leaving it with 1,027 shares, and cut its stake in Gilead Sciences Inc (NASDAQ:GILD).

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Fool.com which released: “5 Reasons the Boring Parts of Johnson & Johnson’s Business Should Generate …” on June 18, 2017, also Seekingalpha.com with their article: “Johnson & Johnson’s (JNJ) Management Presents at Goldman Sachs 38th Annual …” published on June 15, 2017, Fiercebiotech.com published: “Johnson & Johnson unveils new obesity, arthritis collaborations, shares its …” on June 15, 2017. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: “Dividend Aristocrats: Abbott Labs Vs. Johnson & Johnson” published on June 12, 2017 as well as Fool.com‘s news article titled: “Johnson & Johnson: The Bear Case From a Bull” with publication date: June 14, 2017.

Johnson & Johnson (NYSE:JNJ) Ratings Coverage

Among 16 analysts covering Johnson & Johnson (NYSE:JNJ), 8 have Buy rating, 1 Sell and 7 Hold. Therefore 50% are positive. Johnson & Johnson had 44 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Hold” on Friday, June 16. Jefferies maintained it with “Hold” rating and $109 target in Tuesday, June 14 report. The stock has “Outperform” rating by RBC Capital Markets on Wednesday, July 20. The stock has “Market Perform” rating by Wells Fargo on Thursday, January 26. The stock of Johnson & Johnson (NYSE:JNJ) has “Buy” rating given on Wednesday, April 20 by Argus Research. Vetr downgraded the stock to “Strong-Buy” rating in Monday, August 31 report. On Tuesday, September 29 the stock rating was upgraded by Deutsche Bank to “Buy”. Cowen & Co maintained Johnson & Johnson (NYSE:JNJ) on Tuesday, August 25 with “Outperform” rating. S&P Research maintained the stock with “Buy” rating in Wednesday, October 14 report. The firm has “Overweight” rating by Barclays Capital given on Wednesday, April 20.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.